Sökning: (WFRF:(Lekakis Lazaros)) >
Outcomes of rituxim...
-
Jagadeesh, DeepaCleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA.
(författare)
Outcomes of rituximab‐BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation
- Artikel/kapitelEngelska2020
Förlag, utgivningsår, omfång ...
-
2020-02-12
-
WILEY,2020
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-425101
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-425101URI
-
https://doi.org/10.1002/cncr.32752DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:142900773URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
BACKGROUND Although rituximab-based high-dose therapy is frequently used in diffuse large B cell lymphoma (DLBCL) patients undergoing autologous hematopoietic cell transplantation (auto-HCT), data supporting the benefits are not available. Herein, we report the impact of rituximab-based conditioning on auto-HCT outcomes in patients who have DLBCL. METHODS Using the Center for International Blood and Marrow Transplant Research (CIBMTR) registry, 862 adult DLBCL patients undergoing auto-HCT between 2003 and 2017 using BEAM (BCNU, etoposide, cytarabine, melphalan) conditioning regimen were included. All patients received frontline rituximab-containing chemoimmunotherapy and had chemosensitive disease pre-HCT. Early chemoimmunotherapy failure was defined as not achieving complete remission (CR) after frontline chemoimmunotherapy or relapse within 1 year of initial diagnosis. The primary outcome was overall survival (OS). RESULTS The study cohort was divided into 2 groups: BEAM (n = 667) and R-BEAM (n = 195). On multivariate analysis, no significant difference was seen in OS (P = .83) or progression-free survival (PFS) (P = .61) across the 2 cohorts. No significant association between the use of rituximab and risk of relapse (P = .15) or nonrelapse mortality (P = .12) was observed. Variables independently associated with lower OS included older age at auto-HCT (P < .001), absence of CR at auto-HCT (P < .001) and early chemoimmunotherapy failure (P < .001). Older age (P < .0002) and non-CR pre-HCT (P < .0001) were also associated with inferior PFS. There was no significant difference in early infectious complications between the 2 cohorts. CONCLUSION In this large registry analysis of DLBCL patients undergoing auto-HCT, the addition of rituximab to the BEAM conditioning regimen had no impact on transplantation outcomes. Older age, absence of CR pre auto-HCT, and early chemoimmunotherapy failure were associated with inferior survival.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Majhail, Navneet S.Cleveland Clin, Taussig Canc Inst, Blood & Marrow Transplant Program, Cleveland, OH 44106 USA.
(författare)
-
He, YizengMed Coll Wisconsin, Div Biostat, Inst Hlth & Equ, Milwaukee, WI 53226 USA.
(författare)
-
Ahn, Kwang W.Med Coll Wisconsin, Div Biostat, Inst Hlth & Equ, Milwaukee, WI 53226 USA.;Med Coll Wisconsin, Dept Med, CIBMTR, Milwaukee, WI 53226 USA.
(författare)
-
Litovich, CarlosMed Coll Wisconsin, Dept Med, CIBMTR, Milwaukee, WI 53226 USA.
(författare)
-
Ahmed, SairahUniv Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.
(författare)
-
Aljurf, MahmoudKing Faisal Specialist Hosp Ctr & Res, Dept Oncol, Riyadh, Saudi Arabia.
(författare)
-
Bacher, UlrikeUniv Bern, Bern Univ Hosp, Inselspital, Dept Hematol, Bern, Switzerland.
(författare)
-
Badawy, Sherif M.Ann & Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol & Stem Cell Transplant, Chicago, IL 60611 USA.;Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA.
(författare)
-
Bejanyan, NelliH Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA.
(författare)
-
Cairo, MitchellNew York Med Coll, Dept Pediat, Div Pediat Hematol Oncol & Stem Cell Transplantat, Valhalla, NY 10595 USA.;Ohio State Univ, Dept Med, James Canc Hosp, Div Hematol, Columbus, OH 43210 USA.
(författare)
-
Cerny, JanUniv Massachusetts, Med Ctr, Dept Med, Div Hematol Oncol, Worcester, MA USA.
(författare)
-
Epperla, NarendranathOhio State Univ, Solove Res Inst, Columbus, OH 43210 USA.
(författare)
-
Farhadfar, NoshaUniv Florida, Coll Med, Div Hematol Oncol, Gainesville, FL USA.
(författare)
-
Freytes, Cesar O.Texas Transplant Inst, San Antonio, TX USA.
(författare)
-
Gale, Robert PeterImperial Coll London, Dept Med, Div Expt Med, Hematol Res Ctr, London, England.
(författare)
-
Haverkos, BradleyUniv Colorado Hosp, Aurora, CO USA.
(författare)
-
Hossain, NasheedLoyola Univ, Chicago Stritch Sch Med, Dept Med, Stem Cell Transplant Program,Div Hematol Oncol, Maywood, IL 60153 USA.
(författare)
-
Inwards, DavidMayo Clin, Div Hematol, Rochester, MN USA.
(författare)
-
Kamble, Rammurti T.Baylor Coll Med, Div Hematol & Oncol, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.
(författare)
-
Kenkre, Vaishalee P.Univ Wisconsin, Div Hematol Oncol, Madison, WI USA.
(författare)
-
Lazarus, Hillard M.Case Western Reserve Univ, Div Hematol Oncol, Cleveland, OH 44106 USA.
(författare)
-
Lazaryan, AleksandrH Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA.
(författare)
-
Lekakis, LazarosUniv Miami, Dept Hematol Oncol, Miami, FL USA.
(författare)
-
Mei, MatthewCity Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA.
(författare)
-
Murthy, Hemant S.Mayo Clin Florida, Div Hematol Oncol, Blood & Marrow Transplantat Program, Jacksonville, FL USA.
(författare)
-
Mussetti, AlbertoInst Catala Oncol Hosp, Dept Hematol, Barcelona, Spain.;IDIBELL Inst Catala Oncol, Lhospitalet De Llobregat, El Prat De Llob, Spain.
(författare)
-
Nathan, SunitaRush Univ, Div Hematol Oncol & Cell Therapy, Med Ctr, Chicago, IL 60612 USA.
(författare)
-
Nishihori, TaigaH Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA.
(författare)
-
Olsson, RichardKarolinska Institutet,Uppsala universitet,Centrum för klinisk forskning i Sörmland (CKFD),Karolinska Inst, Dept Lab Med, Stockholm, Sweden.(Swepub:uu)riols677
(författare)
-
Geethakumari, Praveen RamakrishnanUniv Texas Southwestern Med Ctr, Lymphoma BMT & Cellular Therapy Program, Dallas, TX USA.
(författare)
-
Savani, Bipin N.Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA.
(författare)
-
Yared, Jean A.Univ Maryland, Dept Med, Blood & Marrow Transplantat Program, Greenebaum Comprehens Canc Ctr,Div Hematol Oncol, Baltimore, MD 21201 USA.
(författare)
-
Fenske, Timothy S.Med Coll Wisconsin, Dept Med, Div Hematol & Oncol, Milwaukee, WI 53226 USA.
(författare)
-
Kharfan-Dabaja, Mohamed A.Mayo Clin Florida, Div Hematol Oncol, Blood & Marrow Transplantat Program, Jacksonville, FL USA.
(författare)
-
Sureda, AnnaInst Catala Oncol Hosp, Dept Hematol, Barcelona, Spain.;IDIBELL Inst Catala Oncol, Lhospitalet De Llobregat, El Prat De Llob, Spain.
(författare)
-
Hamadani, MehdiMed Coll Wisconsin, Dept Med, CIBMTR, Milwaukee, WI 53226 USA.
(författare)
-
Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA.Cleveland Clin, Taussig Canc Inst, Blood & Marrow Transplant Program, Cleveland, OH 44106 USA.
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Cancer: WILEY126:10, s. 2279-22870008-543X1097-0142
Internetlänk
Hitta via bibliotek
-
Cancer
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Jagadeesh, Deepa
-
Majhail, Navneet ...
-
He, Yizeng
-
Ahn, Kwang W.
-
Litovich, Carlos
-
Ahmed, Sairah
-
visa fler...
-
Aljurf, Mahmoud
-
Bacher, Ulrike
-
Badawy, Sherif M ...
-
Bejanyan, Nelli
-
Cairo, Mitchell
-
Cerny, Jan
-
Epperla, Narendr ...
-
Farhadfar, Nosha
-
Freytes, Cesar O ...
-
Gale, Robert Pet ...
-
Haverkos, Bradle ...
-
Hossain, Nasheed
-
Inwards, David
-
Kamble, Rammurti ...
-
Kenkre, Vaishale ...
-
Lazarus, Hillard ...
-
Lazaryan, Aleksa ...
-
Lekakis, Lazaros
-
Mei, Matthew
-
Murthy, Hemant S ...
-
Mussetti, Albert ...
-
Nathan, Sunita
-
Nishihori, Taiga
-
Olsson, Richard
-
Geethakumari, Pr ...
-
Savani, Bipin N.
-
Yared, Jean A.
-
Fenske, Timothy ...
-
Kharfan-Dabaja, ...
-
Sureda, Anna
-
Hamadani, Mehdi
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Hematologi
- Artiklar i publikationen
-
Cancer
- Av lärosätet
-
Uppsala universitet
-
Karolinska Institutet